News of the index components FTSE 100

Index

UKX

GB0001383545

Real-time Estimate TTMZero 09:37:47 06/06/2024 BST			5-day change	1st Jan Change
8,267 ^PTS	+0.25%		+0.48%	+6.95%

05-25	Sunak's summer election brings hope to Britain's bruised financial sector	RE
05-24	IWG confirms name change to International Workplace Group	AN

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UK Regulator Terminates Inquiry Extension in Vodafone-CK Hutchison JV Probe VOD	06-03	MT
Deltic Energy gets short extra time from Shell at Pensacola SHEL	06-03	AN
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc SMDS	06-03	EQ
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc BDEV	06-03	EQ
Trending : GSK Shares Tumble on Zantac's Legal Setback GSK	06-03	DJ
South African Court Lifts Suspension on Shell’s Eastern Cape Exploration SHEL	06-03	MT
Sector Update: Health Care Stocks Steady Premarket Monday GSK	06-03	MT
KRATON CORPORATION ANNOUNCES A GLOBAL PRICE INCREASE FOR USBC AND HSBC PRODUCTS HSBA	06-03	AQ
GSK Says Cancer Drug Jemperli Shows 100% Clinical Response Rate in Long-Term Data From Mid-Stage Trial GSK	06-03	MT
GSK immunotherapy bowel cancer drug works for 100% of patients GSK	06-03	AN
GSK : Jemperli (dostarlimab) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer - Form 6-K GSK	06-03	PU
Sector Update: Health Care GSK	06-03	MT
AstraZeneca immunotherapy could boost lung cancer survival AZN	06-03	AQ
Aviva Non-Exec Cheryl Agius buys GBP72,000 in shares AV.	06-03	AN
RIO TINTO : Buy rating from JP Morgan RIO	06-03	ZD
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer GSK	06-03	BU
GSK : Jemperli (dostarlimab) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer GSK	06-03	PU
Jefferies Lifts Berkeley Group PT, Affirms Hold Rating BKG	06-03	MT
Berenberg Lifts Auto Trader PT, Keeps Hold Rating AUTO	06-03	MT
JPMorgan Upgrades St. James's Place to Overweight from Neutral, Lifts PT STJ	06-03	MT
Goldman Lifts Coca-Cola HBC PT, Affirms Buy Rating CCH	06-03	MT
Goldman Sachs Downgrades Land Securities to Neutral from Buy, Cuts PT LAND	06-03	MT
Goldman Sachs Lifts Segro PT, Maintains Neutral Rating SGRO	06-03	MT
Bernstein Lowers National Grid PT, Affirms Market Perform Rating NG.	06-03	MT
GSK to Face Trials Over Zantac Cancer Allegations; Shares Tumble Pre-Bell GSK	06-03	MT
National Grid : NIMO Factsheet 2024 NG.	06-03	PU
GSK : Sell rating from JP Morgan GSK	06-03	ZD
ASTRAZENECA : JP Morgan remains its Buy rating AZN	06-03	ZD
GSK : Deutsche Bank reiterates its Buy rating GSK	06-03	ZD
Pershing Square Holdings, Ltd. Notes the Sale by Pershing Square Capital Management, L.P. of a 10% Common Equity Interest to Strategic Investors PSH	06-03	BU
FTSE 100 up, while Labour commits to defence GSK	06-03	AN
RELX brings its AI to law firms' data with Henchman tech deal REL	06-03	RE
GSK : Goldman Sachs remains Neutral GSK	06-03	ZD
AstraZeneca : Tagrisso with the addition of chemotherapy recommended for approval in the EU by CHMP for patients with EGFR-mutated advanced lung cancer - Form 6-K AZN	06-03	PU
South African appeal court throws lifeline to Shell's Wild Coast exploration SHEL	06-03	RE
British American Tobacco p l c : 27.05.2024 – 31.05.2024 (03.06.2024 FCA Buy Back Submission) BATS	06-03	PU
GSK Shares Plunge After Delaware Ruling Allowing Jury Trials for Zantac Case -- Update GSK	06-03	DJ
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares SMDS	06-03	AQ
GSK : Blenrep combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma - Form 6-K GSK	06-03	PU
Centrica : People & Planet Plan Report 2023 CNA	06-03	PU